Childhood Cancer STAR Reauthorization Act

Bill: 117-s-4120
Sponsor: full_name: Sen. Reed, Jack [D-RI]
Introduced: 2022-04-28
Policy area: Health
Subjects: Cancer

Child health

Computers and information technology

Congressional oversight

Government studies and investigations

Health programs administration and funding

Health technology, devices, supplies

Medical research

Research administration and funding

Research and development
Latest action: action_date: 2023-01-05
text: Became Public Law No: 117-350.

Summaries:
action_date: 2022-04-28
action_desc: Introduced in Senate
text: <p><strong>Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act</strong></p> <p>This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.</p>

action_date: 2022-12-20
action_desc: Passed Senate
text: <p><strong>Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act</strong></p> <p>This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.</p>

action_date: 2022-12-22
action_desc: Passed House
text: <p><strong>Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act</strong></p> <p>This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.</p>

action_date: 2023-01-05
action_desc: Public Law
text: <p><strong>Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act</strong></p> <p>This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.</p>

tv_txt: II 117th CONGRESS 2d Session S. 4120 IN THE SENATE OF THE UNITED STATES April 28, 2022 Mr. Reed (for himself, Mrs. Capito , Mr. Van Hollen , and Ms. Murkowski ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

1. Short title This Act may be cited as the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act . 2. Reauthorizing and improving the Childhood STAR Act (a) Children's cancer biorepositories Section 417E of the Public Health Service Act ( 42 U.S.C. 285a–11 ) is amended— (1) in subsection (a)— (A) in paragraph (2)(A), by inserting before the period at the end of the second sentence the following: , and providing sample collection incentives for both solid tumor cancer and paired tissues for all pediatric cancers ; (B) in paragraph (9), by striking Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 and inserting Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; (C) by redesignating paragraph (10) as paragraph (11); and (D) by inserting after paragraph (9) the following: (10) Report on researcher access to children's cancer biorepository samples The Director of NIH shall, not later than 2 years after the date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 , submit to Congress a report on policy changes that would facilitate streamlining the approval process for researcher access to children's cancer biorepository samples, with a special focus on lowering the regulatory burden before samples can be sent to investigators. ; and (2) in subsection (d), by striking 2019 through 2023 and inserting 2024 through 2028 . (b) Cancer survivorship programs Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 ( Public Law 115–180 ) is amended— (1) in subsection (a)— (A) in paragraph (1), by striking may make awards and inserting shall make awards ; and (B) by adding at the end the following: (4) Consideration In developing, studying, and evaluating model systems pursuant to this subsection, recipients of awards under this subsection shall give particular consideration to the report issued by the Agency for Healthcare Research and Quality in February 2022, titled Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review . ; and (2) in subsection (b), in paragraphs (1) and (2), by striking date of enactment of this Act each place it appears and inserting date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 . (c) Survivorship electronic health records The Secretary of Health and Human Services shall coordinate with the Office of the National Coordinator for Health Information to prepare a report on the role that tailored survivorship electronic health records can play in life-long health care for childhood cancer survivors, with a special focus on survivors who face unique lifelong health needs and late effects as they transition to primary care. Such report shall be submitted to Congress not later than 2 years after the date of enactment of this Act. (d) Sense of Congress regarding the creation of a childhood cancer medical code It is the sense of Congress that the National Center for Health Statistics at the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services should consider adding a new Childhood Cancer Code to the International Classification of Diseases (ICD) system for the purpose of facilitating access to existing insurance coverage of childhood cancer patients and survivors, as appropriate.

tv_txt: One Hundred Seventeenth Congress of the United States of America 2d Session Begun and held at the City of Washington on Monday, the third day of January, two thousand and twenty two S. 4120 IN THE SENATE OF THE UNITED STATES AN ACT To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

1. Short title This Act may be cited as the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act . 2. Reauthorizing and improving the Childhood STAR Act (a) Children's cancer biorepositories Section 417E of the Public Health Service Act ( 42 U.S.C. 285a–11 ) is amended— (1) in subsection (a)— (A) in paragraph (2)(A), by inserting before the period at the end of the second sentence the following: , such as collected samples of both solid tumor cancer and paired samples ; (B) in paragraph (9), by striking Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 and inserting Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; (C) by redesignating paragraph (10) as paragraph (11); and (D) by inserting after paragraph (9) the following: (10) Report on researcher access to children's cancer biorepository samples Not later than 2 years after the date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 , the Director of NIH shall— (A) conduct a review of the procedures established under paragraph (2)(C) and other policies or procedures related to researcher access to such biospecimens to identify any opportunities to reduce administrative burden, consistent with paragraph (2)(D), in a manner that protects personal privacy to the extent required by applicable Federal and State privacy law, at a minimum; and (B) submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of the review under subparagraph (A) and whether the Director of NIH plans to make any changes to the policies or procedures considered in such review, based on such findings. ; and (2) in subsection (d), by striking 2019 through 2023 and inserting 2024 through 2028 . (b) Cancer survivorship programs Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 ( Public Law 115–180 ) is amended— (1) in subsection (a)— (A) in the subsection heading, by striking Pilot programs to explore and inserting Research to evaluate (B) in paragraph (1)— (i) by striking may make awards to eligible entities to establish pilot programs and inserting shall, as appropriate, make awards to eligible entities to conduct or support research ; (ii) by striking model systems and inserting approaches ; (iii) by inserting and adolescent after childhood ; and (iv) by striking evaluation of models for ; (C) in paragraph (2)— (i) in subparagraph (A), in the matter preceding clause (i), by inserting within the existing peer review process, after practicable, ; and (ii) in subparagraph (B)(v), by striking in treating survivors of childhood cancers and inserting in carrying out the activities described in paragraph (1) ; and (D) in paragraph (3)(B)(v), by striking design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers and inserting design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts ; and (2) in subsection (b)— (A) in each of paragraphs (1) and (2), by striking date of enactment of this Act and inserting date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; and (B) in paragraph (1)— (i) by striking subparagraphs (A) and (C); (ii) by redesignating subparagraph (B) as subparagraph (A); and (iii) by adding at the end the following: (B) recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors. .

Speaker of the House of Representatives Vice President of the United States and President of the Senate

tv_txt: 117th CONGRESS 2d Session S. 4120 IN THE SENATE OF THE UNITED STATES AN ACT To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

1. Short title This Act may be cited as the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act . 2. Reauthorizing and improving the Childhood STAR Act (a) Children's cancer biorepositories Section 417E of the Public Health Service Act ( 42 U.S.C. 285a–11 ) is amended— (1) in subsection (a)— (A) in paragraph (2)(A), by inserting before the period at the end of the second sentence the following: , such as collected samples of both solid tumor cancer and paired samples ; (B) in paragraph (9), by striking Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 and inserting Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; (C) by redesignating paragraph (10) as paragraph (11); and (D) by inserting after paragraph (9) the following: (10) Report on researcher access to children's cancer biorepository samples Not later than 2 years after the date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 , the Director of NIH shall— (A) conduct a review of the procedures established under paragraph (2)(C) and other policies or procedures related to researcher access to such biospecimens to identify any opportunities to reduce administrative burden, consistent with paragraph (2)(D), in a manner that protects personal privacy to the extent required by applicable Federal and State privacy law, at a minimum; and (B) submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of the review under subparagraph (A) and whether the Director of NIH plans to make any changes to the policies or procedures considered in such review, based on such findings. ; and (2) in subsection (d), by striking 2019 through 2023 and inserting 2024 through 2028 . (b) Cancer survivorship programs Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 ( Public Law 115–180 ) is amended— (1) in subsection (a)— (A) in the subsection heading, by striking Pilot programs to explore and inserting Research to evaluate (B) in paragraph (1)— (i) by striking may make awards to eligible entities to establish pilot programs and inserting shall, as appropriate, make awards to eligible entities to conduct or support research ; (ii) by striking model systems and inserting approaches ; (iii) by inserting and adolescent after childhood ; and (iv) by striking evaluation of models for ; (C) in paragraph (2)— (i) in subparagraph (A), in the matter preceding clause (i), by inserting within the existing peer review process, after practicable, ; and (ii) in subparagraph (B)(v), by striking in treating survivors of childhood cancers and inserting in carrying out the activities described in paragraph (1) ; and (D) in paragraph (3)(B)(v), by striking design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers and inserting design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts ; and (2) in subsection (b)— (A) in each of paragraphs (1) and (2), by striking date of enactment of this Act and inserting date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; and (B) in paragraph (1)— (i) by striking subparagraphs (A) and (C); (ii) by redesignating subparagraph (B) as subparagraph (A); and (iii) by adding at the end the following: (B) recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors. .

Passed the Senate December 20, 2022. Secretary